Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 69.70
-1.72 (-2.41%)
Jun 1, 2026, 3:29 PM IST
Alpa Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,058 | 1,125 | 1,087 | 929.55 | 1,123 |
Other Revenue | 157.57 | - | - | - | - |
| 1,216 | 1,125 | 1,087 | 929.55 | 1,123 | |
Revenue Growth (YoY) | 8.11% | 3.42% | 16.98% | -17.20% | 15.08% |
Cost of Revenue | 743.02 | 760.44 | 746.04 | 616.67 | 761.06 |
Gross Profit | 472.64 | 364.08 | 341.35 | 312.89 | 361.61 |
Selling, General & Admin | 158.07 | 149.55 | 156.15 | 125.47 | 122.82 |
Other Operating Expenses | 124.1 | 167.5 | 99.08 | 106.51 | 132.16 |
Operating Expenses | 303.09 | 339.08 | 274.77 | 245.27 | 271.55 |
Operating Income | 169.55 | 25.01 | 66.58 | 67.62 | 90.06 |
Interest Expense | -2.58 | -2.32 | -3.59 | -0.83 | -1.07 |
Interest & Investment Income | - | 24.11 | 25.63 | 12.3 | 15.27 |
Earnings From Equity Investments | - | - | - | -0 | 0.07 |
Currency Exchange Gain (Loss) | - | 8.57 | 7.39 | 19.56 | 2.61 |
Other Non Operating Income (Expenses) | - | 3.03 | 20.47 | 27.41 | 0.36 |
EBT Excluding Unusual Items | 166.97 | 58.39 | 116.48 | 126.06 | 107.3 |
Gain (Loss) on Sale of Investments | - | 197.78 | 90.34 | 32.97 | 88.32 |
Gain (Loss) on Sale of Assets | - | 0.5 | - | -0.12 | - |
Pretax Income | 166.97 | 256.67 | 206.82 | 158.9 | 195.62 |
Income Tax Expense | 16.87 | 61.64 | 39.06 | 33.08 | 54.7 |
Net Income | 150.1 | 195.03 | 167.77 | 125.83 | 140.92 |
Net Income to Common | 150.1 | 195.03 | 167.77 | 125.83 | 140.92 |
Net Income Growth | -23.04% | 16.25% | 33.33% | -10.71% | 94.45% |
Shares Outstanding (Basic) | 58 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 58 | 21 | 21 | 21 | 21 |
Shares Change (YoY) | 173.80% | - | - | - | -0.00% |
EPS (Basic) | 2.61 | 9.27 | 7.97 | 5.98 | 6.70 |
EPS (Diluted) | 2.61 | 9.27 | 7.97 | 5.98 | 6.70 |
EPS Growth | -71.89% | 16.25% | 33.33% | -10.71% | 94.45% |
Free Cash Flow | 59.97 | 69.39 | -27.37 | 77.78 | 77.49 |
Free Cash Flow Per Share | 1.04 | 3.30 | -1.30 | 3.70 | 3.68 |
Gross Margin | 38.88% | 32.38% | 31.39% | 33.66% | 32.21% |
Operating Margin | 13.95% | 2.22% | 6.12% | 7.27% | 8.02% |
Profit Margin | 12.35% | 17.34% | 15.43% | 13.54% | 12.55% |
Free Cash Flow Margin | 4.93% | 6.17% | -2.52% | 8.37% | 6.90% |
EBITDA | 190.47 | 47.03 | 86.13 | 80.91 | 106.63 |
EBITDA Margin | 15.67% | 4.18% | 7.92% | 8.70% | 9.50% |
D&A For EBITDA | 20.92 | 22.02 | 19.55 | 13.29 | 16.57 |
EBIT | 169.55 | 25.01 | 66.58 | 67.62 | 90.06 |
EBIT Margin | 13.95% | 2.22% | 6.12% | 7.27% | 8.02% |
Effective Tax Rate | 10.11% | 24.02% | 18.88% | 20.82% | 27.96% |
Revenue as Reported | 1,216 | 1,358 | 1,236 | 1,023 | 1,230 |
Advertising Expenses | - | 4.88 | 22.53 | 3.11 | 2.77 |